PharmaEngine (Taiwan) Today

4162 Stock  TWD 93.60  1.00  1.08%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
PharmaEngine is selling for under 93.60 as of the 19th of April 2024; that is 1.08 percent increase since the beginning of the trading day. The stock's lowest day price was 91.9. PharmaEngine has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for PharmaEngine are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.

Moving together with PharmaEngine Stock

  0.674743 Oneness BiotechPairCorr
  0.726589 EirGenixPairCorr
  0.76547 Medigen Vaccine BiologicsPairCorr
  0.854174 OBI PharmaPairCorr
  0.746541 Tanvex BioPharmaPairCorr
  0.714142 Adimmune CorpPairCorr

Moving against PharmaEngine Stock

  0.690050 YuantaP shares TaiwanPairCorr
  0.690057 Fubon MSCI TaiwanPairCorr
  0.680053 YuantaP shares TaiwanPairCorr
  0.659933 CTCI CorpPairCorr
  0.636428 Taiwan TaomeePairCorr
  0.66223 MPI CorporationPairCorr
  0.60051 YuantaP shares TaiwanPairCorr

PharmaEngine Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PharmaEngine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PharmaEngine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, General Manager, DirectorChangjing Ye
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
PharmaEngine (4162) is traded on Taiwan OTC Exchange in Taiwan and employs 41 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PharmaEngine's market, we take the total number of its shares issued and multiply it by PharmaEngine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PharmaEngine operates under Healthcare sector and is part of Biotechnology industry. The entity has 143.69 M outstanding shares. PharmaEngine generates positive cash flow from operations, but has no cash available
Check PharmaEngine Probability Of Bankruptcy
Ownership Allocation
PharmaEngine owns a total of 143.69 Million outstanding shares. PharmaEngine has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PharmaEngine Ownership Details

PharmaEngine Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of PharmaEngine jumping above the current price in 90 days from now is about 92.67%. The PharmaEngine probability density function shows the probability of PharmaEngine stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon PharmaEngine has a beta of 0.3028. This suggests as returns on the market go up, PharmaEngine average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding PharmaEngine will be expected to be much smaller as well. Additionally, pharmaEngine has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 93.6HorizonTargetOdds Above 93.6
7.24%90 days
 93.60 
92.67%
Based on a normal probability distribution, the odds of PharmaEngine to move above the current price in 90 days from now is about 92.67 (This PharmaEngine probability density function shows the probability of PharmaEngine Stock to fall within a particular range of prices over 90 days) .

PharmaEngine Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. PharmaEngine market risk premium is the additional return an investor will receive from holding PharmaEngine long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PharmaEngine. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although PharmaEngine's alpha and beta are two of the key measurements used to evaluate PharmaEngine's performance over the market, the standard measures of volatility play an important role as well.

PharmaEngine Stock Against Markets

Picking the right benchmark for PharmaEngine stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PharmaEngine stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PharmaEngine is critical whether you are bullish or bearish towards PharmaEngine at a given time. Please also check how PharmaEngine's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in PharmaEngine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

PharmaEngine Corporate Directors

PharmaEngine corporate directors refer to members of a PharmaEngine board of directors. The board of directors generally takes responsibility for the PharmaEngine's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PharmaEngine's board members must vote for the resolution. The PharmaEngine board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy PharmaEngine Stock?

Before investing in PharmaEngine, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in PharmaEngine. To buy PharmaEngine stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of PharmaEngine. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase PharmaEngine stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located PharmaEngine stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased PharmaEngine stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as PharmaEngine, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in PharmaEngine?

The danger of trading PharmaEngine is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PharmaEngine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PharmaEngine. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PharmaEngine is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for PharmaEngine Stock analysis

When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Please note, there is a significant difference between PharmaEngine's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaEngine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaEngine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.